The primary objective was to recognize suitable analytical targets by analyzing human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to substantiate the results in reliable urine specimens and to determine AB-FUBINACA's metabolic security in human liver microsomes and as opposed hepatocyte and urine results with in